Cargando…

Providing antiretroviral therapy to all who are HIV positive: the clinical, public health and programmatic benefits of Treat All

Detalles Bibliográficos
Autores principales:	Ford, Nathan, Vitoria, Marco, Doherty, Meg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Viewpoint
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5810349/ https://www.ncbi.nlm.nih.gov/pubmed/29436776 http://dx.doi.org/10.1002/jia2.25078

Ejemplares similares

Getting to zero HIV deaths: progress, challenges and ways forward
por: Ford, Nathan, et al.
Publicado: (2013)

The contribution of observational studies in supporting the WHO ‘treat all’ recommendation for HIV/AIDS
por: Ford, Nathan, et al.
Publicado: (2018)

Programmatic Mapping: Providing Evidence for High Impact HIV Prevention Programs for Female Sex Workers
por: Emmanuel, Faran, et al.
Publicado: (2019)

Primary or secondary prevention of HIV-associated histoplasmosis during the early antiretrovirals for all era
por: Nacher, Mathieu, et al.
Publicado: (2023)

Programmatic outcomes and impact of rapid public sector antiretroviral therapy expansion in adults prior to introduction of the WHO treat‐all approach in rural Eswatini
por: Kerschberger, Bernhard, et al.
Publicado: (2019)

WHO guidance to support HIV care models during the Covid-19 era
por: Ford, Nathan, et al.
Publicado: (2021)

From Health in All Policies to Health for All Policies
por: Greer, Scott L, et al.
Publicado: (2022)

Benefits and risks of rapid initiation of antiretroviral therapy
por: Ford, Nathan, et al.
Publicado: (2018)

Not All Canadian Cancer Patients Are Equal—Disparities in Public Cancer Drug Funding across Canada
por: MacPhail, Ceilidh, et al.
Publicado: (2022)

Immediate Breast Reconstruction for All?
por: Jacobson, Galia, et al.
Publicado: (2020)

Prescribing generics: All in a name
por: Roy, Vandana, et al.
Publicado: (2018)

Reimagining HIV service delivery: the role of differentiated care from prevention to suppression
por: Grimsrud, Anna, et al.
Publicado: (2016)

Benefits and limitations of different study designs for long‐acting antiretroviral therapy among people living with HIV with viremia
por: Gandhi, Monica, et al.
Publicado: (2023)

Making plant science purposeful and relevant to all
por: Flavell, Richard
Publicado: (2016)

The road towards protection of all against tetanus
por: Khan, Md. Abdullah Saeed, et al.
Publicado: (2023)

Choice of antiretroviral drugs for continued treatment scale-up in a public health approach: what more do we need to know?
por: Vitoria, Marco, et al.
Publicado: (2016)

One drug to treat them all: ethical implications of the MORDOR trial of mass antibiotic administration to reduce child mortality
por: Tam, Clarence C, et al.
Publicado: (2019)

COVID-19 vaccines protect children of all ages
por: Amarin, Justin Z., et al.
Publicado: (2022)

SLE is not a one-size-fits-all disease
por: Ehrenstein, Michael R., et al.
Publicado: (2023)

Biologics, Pharmacovigilance, and Patient Safety: It’s All in the Name
por: Stevenson, James G., et al.
Publicado: (2016)

HIV programmatic outcomes following implementation of the ‘Treat‐All’ policy in a public sector setting in Eswatini: a prospective cohort study
por: Kerschberger, Bernhard, et al.
Publicado: (2020)

Malignancy and all-cause mortality; incidence in adolescents and young adults living with perinatally acquired HIV
por: Chhabra, Srishti, et al.
Publicado: (2020)

Patient-mix, programmatic characteristics, retention and predictors of attrition among patients starting antiretroviral therapy (ART) before and after the implementation of HIV “Treat All” in Zimbabwe
por: Makurumidze, Richard, et al.
Publicado: (2020)

From policy to action: how to operationalize the treatment for all agenda
por: Celletti, Francesca, et al.
Publicado: (2016)

Introducing an All-mechanized Surgical Assistant for Use in Reconstructive Surgeries
por: Sowa, Yoshihiro, et al.
Publicado: (2019)

All means all: An introduction to the 2020 Global Education Monitoring Report on inclusion
por: Antoninis, Manos, et al.
Publicado: (2020)

Long‐acting injectable cabotegravir: implementation science needed to advance this additional HIV prevention choice
por: Schmidt, Heather‐Marie Ann, et al.
Publicado: (2022)

Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment
por: Ford, Nathan, et al.
Publicado: (2020)

Service integration: opportunities to expand access to antiretroviral therapy for people who inject drugs in Tanzania
por: Lambdin, Barrot H, et al.
Publicado: (2015)

For the love of all that is holy, stop prescribing sodium valproate and carbamazepine together
por: Jawaid, Wajid
Publicado: (2023)

Future schistosome hybridizations: Will all Schistosoma haematobium hybrids please stand-up!
por: Stothard, J. Russell, et al.
Publicado: (2020)

Monitoring climate change and child health: The case for putting children in all policies
por: Romanello, Marina, et al.
Publicado: (2021)

Attrition one year after starting antiretroviral therapy before and after the programmatic implementation of HIV “Treat All” in Sub-Saharan Africa: a systematic review and meta-analysis
por: Makurumidze, Richard, et al.
Publicado: (2023)

Can phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibition ERase them all?
por: Meyer, Dominique S, et al.
Publicado: (2010)

Bereavement management during COVID-19 Pandemic: One size may not fit all!
por: Rammohan, Ashwin, et al.
Publicado: (2021)

A “Good Death” for All: The Need to Teach Racially Sensitive End-of-Life Care
por: Williams, Derrick W., et al.
Publicado: (2022)

Does one size fit all? Differences between islands in Tuvalu and ecological perspectives
por: Lin, Po-Jen, et al.
Publicado: (2022)

One size does not fit all: community views on choices for TB treatment and prevention
por: Makone, A., et al.
Publicado: (2023)

Economic Considerations in Infectious Diseases Emergency Response Preparedness: It’s All About the Point of View
por: Branch-Elliman, Westyn, et al.
Publicado: (2020)

It's all in the blood: circulating endothelial progenitor cells link synovial vascularity with cardiovascular mortality in rheumatoid arthritis?
por: Paleolog, Ewa
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_jipe3qjbmp9a47lt01lf0nbhfp